Accessibility Menu
 
RenovoRx logo

RenovoRx

(NASDAQ) RNXT

Current Price$0.98
Market Cap$36.65M
Since IPO (2021)-86%
5 YearN/A
1 Year+1%
1 Month+0%

RenovoRx Financials at a Glance

Market Cap

$36.65M

Revenue (TTM)

$928.00K

Net Income (TTM)

$11.11M

EPS (TTM)

$-0.36

P/E Ratio

-2.81

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.98

Volume

1,100

Open

$1.01

Previous Close

$0.98

Daily Range

$0.98 - $1.01

52-Week Range

$0.70 - $1.45

RNXT News

RNXT: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About RenovoRx

Industry

Biotechnology

Employees

10

CEO

Shaun R. Bagai

Headquarters

Mountain View, CA 94022, US

RNXT Financials

Key Financial Metrics (TTM)

Gross Margin

68%

Operating Margin

-13%

Net Income Margin

-12%

Return on Equity

-147%

Return on Capital

-1%

Return on Assets

-99%

Earnings Yield

-35.59%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$36.65M

Shares Outstanding

36.65M

Volume

1.10K

Short Interest

0.00%

Avg. Volume

295.91K

Financials (TTM)

Gross Profit

$43.00K

Operating Income

$10.97M

EBITDA

$10.97M

Operating Cash Flow

$9.13M

Capital Expenditure

$12.00K

Free Cash Flow

$9.14M

Cash & ST Invst.

$7.15M

Total Debt

$278.00K

RenovoRx Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$266.00K

N/A

Gross Profit

$213.00K

N/A

Gross Margin

80.08%

N/A

Market Cap

$36.65M

N/A

Market Cap/Employee

$3.66M

N/A

Employees

10

N/A

Net Income

$2.91M

-17.8%

EBITDA

$2.91M

-2.9%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$9.81M

+2.6%

Accounts Receivable

$169.00K

N/A

Inventory

$272.00K

N/A

Long Term Debt

$134.00K

N/A

Short Term Debt

$102.00K

N/A

Return on Assets

-99.10%

N/A

Return on Invested Capital

-1.25%

N/A

Free Cash Flow

$2.27M

-3.5%

Operating Cash Flow

$2.27M

-3.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TVRDTvardi Therapeutics, Inc.
$3.52-4.35%
PYPDPolyPid Ltd.
$4.16-4.81%
CELUCelularity Inc.
$1.22-3.94%
ELUTElutia Inc.
$1.10+4.76%

Trending Stocks

Symbol / CompanyPricePrice Chg
CMCSAComcast
$29.02+0.00%
INTCIntel
$43.87-0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%

Questions About RNXT

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.